Oligonucleotide synthesis market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
What the Market Looks Like?
The global oligonucleotide synthesis market is projected to reach USD 8.2 billion by 2024 from USD 4.3 billion in 2019, at a CAGR of 13.7%.
Therapeutic Application:
The therapeutic applications segment, which is further segmented into RNAi oligonucleotide-based therapies, DNA & antisense oligonucleotide-based therapies, and CpG oligonucleotide-based therapies, is estimated to witness the highest growth during the forecast period. This can primarily be attributed to the investments made by companies to explore the therapeutic applications of oligos. Also, from 2016 to 2018, more than five oligonucleotide-based therapies were approved by the FDA. In 2018, these oligonucleotide-based drugs generated a revenue of ~USD 2 billion. Apart from this, there are a couple of oligonucleotide-based drugs in Phase III and FDA review, and these drugs might be launched in the next five years and may positively impact this market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350
Oligonucleotide-based Drugs:
Oligonucleotide-based accounted for over 50% of the synthesized oligos market share in 2018. This segment is also estimated to grow at the highest CAGR during the forecast period due to the increasing demand for oligonucleotide-based drugs and the influx of new customers in the oligo drug development arena. Apart from this, there are a few oligonucleotide-based drugs in Phase III and FDA review, and these drugs might be launched over the next five years which will positively impact this market.
North America and Europe to Dominate Oligonucleotide Synthesis Industry:
The global oligonucleotide synthesis industry is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America was the largest market for share, followed by Europe. Moreover, North America is estimated to register the highest CAGR during the forecast period primarily due to the increasing R&D activities and the growing number of oligonucleotide-based drugs/therapies being approved by the FDA.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350
Key Players in Oligonucleotide Synthesis Market:
The key players operating in this market include Agilent Technologies, Inc. (US), ATDBio Ltd. (UK), Bio-Synthesis, Inc. (US), BioAutomation Corporation (US), LGC Biosearch Technologies (US), Biogen International (US), Sarepta Therapeutics (US), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign, Inc. (Japan), GE Healthcare (US), GenScript, Inc. (US), Integrated DNA Technologies (IDT, US), Nitto Denko Avecia, Inc. (US), Sarepta Therapeutics (US), Thermo Fisher Scientific, Inc. (US), TriLink BioTechnologies (US), and Sigma-Aldrich Corporation (US) (a part of Merck KGAA).
Oligonucleotide Synthesis Market to Reflect Impressive Growth in Biotechnology Sector
With a fixated viewpoint concerning the global aptamer market, it is examined that application benefits are currently restricted to the pharmaceutical industry.
However, intense research & development initiatives carried out by leading players active in the aptamer market are likely to widen existing usage of these neoteric molecules, thereby creating smooth market opportunities.The business intelligence study of the aptamer market covers the estimation size of the market both in terms of value and volume.
In a bid to recognize the growth prospects in the aptamer market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market.
Each segment of the aptamer market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:North America (Canada, US)Latin America (Argentina, Mexico)Europe (NORDIC, UK)APEJ (China, India)Get Customize Sample Copy of Report from Here - https://www.factmr.com/connectus/sample?flag=S_id=173According to research findings, the application of aptamers are likely to expand across the food and beverage industry as biosensors so as to ensure the quality of products.
Looking at all such favorable influences, it is assessed that the global aptamer market is anticipated to progress at an inspiring CAGR growth rate of 21% during the forecast period (2020-2025).Concentrated Research Actions in North America Set to Motivate Aptamer Market GrowthPresently, North America enjoys its lead in the aptamer market which is powered by the early-bird’s advantage of progressive technology that manufacturers are unloading in the region.
It should be noted that, continuous development in the research & development of therapeutics as well as diagnostics equipment commenced by research institutes is likely to escalate demand for aptamers.
The report Global Blue Biotechnology Market covers the analysis and forecast of the blue biotechnology market on global as well as regional level, provides historic data of 2016 along with the forecast for the period between 2017 and 2025.The study provides a detailed view of the blue biotechnology market, by segmenting it based on by product type, by application, by end- user and regional demand.
Robust growth of drug discovery in the past several years propels the growth for the blue biotechnologys market.
Growing usage of algae along with other bacteria for producing a new drug is another prime factor driving the market demand.
Extensive use of blue biotechnologys in end-user industries such as pharmaceutical, research organization, healthcare, and others boosts the demand of this market.Leading Market Players of Global blue biotechnology market:Aker BiomarineCellgen Biologicals Pvt Ltd.Donald Danforth Plant Science CenterGeomarine BiotechnologiesGlycomarMarinovaNurture Aqua Technology Pvt.New England BiolabsPicesPml Application Ltd.Global blue biotechnology market has been segmented into:By Product TypePharmaBiofuelsFoodEnzymesBiopolymersBy ApplicationVaccine developmentDrug findingGenomics By End- UserPharmaceutical companiesBiotechnology companiesResearch organizationHealthcare centreBy Regions:North America Europe Asia Pacific Middle East and Africa Latin America Rest of Latin America About Aarkstore EnterpriseAarkstore curates global market research reports from various industry verticals and serves businesses worldwide.
As market research report resellers, we at Aarkstore, partner with established publishers for both; syndicated data and customized reports.
The market research data supplied by us is up-to-date and reliable for current day industry analysis and future market forecasts equally.Avail market research reports from us and gathers critical information about customer preferences, market requirements, key drivers and challenges for your business to align your strategies with them.
Market Research Place has released a new research analysis entitled Global Autoimmune Drugs Market Research Report 2019-2025 provides deep analysis on market-size, shares supply-demand analysis, sales value and volume study of Autoimmune Drugs industry.
The report studies top players with their company profile, growth aspects, opportunities, and threats to market development.
The report covers the current evolution inside the world trade and crucial parts that affect the expansion of the market.
It offers a dynamic vision of the global scenario in terms of market size, market statistics, and the competitive situation.Market Overview:The industry overview portion of the report provides the growth analysis and historical & futuristic cost, revenue, demand and supply data.
It offers readers a holistic view of the global market.
An analysis of the industrial chain, current market fluctuations, and analysis of customers has been served in the report.DOWNLOAD FREE SAMPLE REPORT: https://www.marketresearchplace.com/report-detail/182839/request-sampleKey Points Covered In This Autoimmune Drugs Market Report:Executive Summary: It provides market size with 2018 as the base year in consideration and a yearly forecast until 2025 in terms of revenue (USD Million).Market Dynamics: Key factors that are anticipated to considerably drive or limit the market’s growth are clarified in this research study.
With a fixated viewpoint concerning the global aptamer market, it is examined that application benefits are currently restricted to the pharmaceutical industry.
However, intense research & development initiatives carried out by leading players active in the aptamer market are likely to widen existing usage of these neoteric molecules, thereby creating smooth market opportunities.The business intelligence study of the aptamer market covers the estimation size of the market both in terms of value and volume.
In a bid to recognize the growth prospects in the aptamer market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market.
Each segment of the aptamer market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:North America (Canada, US)Latin America (Argentina, Mexico)Europe (NORDIC, UK)APEJ (China, India)Get Customize Sample Copy of Report from Here - https://www.factmr.com/connectus/sample?flag=S_id=173According to research findings, the application of aptamers are likely to expand across the food and beverage industry as biosensors so as to ensure the quality of products.
Looking at all such favorable influences, it is assessed that the global aptamer market is anticipated to progress at an inspiring CAGR growth rate of 21% during the forecast period (2020-2025).Concentrated Research Actions in North America Set to Motivate Aptamer Market GrowthPresently, North America enjoys its lead in the aptamer market which is powered by the early-bird’s advantage of progressive technology that manufacturers are unloading in the region.
It should be noted that, continuous development in the research & development of therapeutics as well as diagnostics equipment commenced by research institutes is likely to escalate demand for aptamers.
The report Global Blue Biotechnology Market covers the analysis and forecast of the blue biotechnology market on global as well as regional level, provides historic data of 2016 along with the forecast for the period between 2017 and 2025.The study provides a detailed view of the blue biotechnology market, by segmenting it based on by product type, by application, by end- user and regional demand.
Robust growth of drug discovery in the past several years propels the growth for the blue biotechnologys market.
Growing usage of algae along with other bacteria for producing a new drug is another prime factor driving the market demand.
Extensive use of blue biotechnologys in end-user industries such as pharmaceutical, research organization, healthcare, and others boosts the demand of this market.Leading Market Players of Global blue biotechnology market:Aker BiomarineCellgen Biologicals Pvt Ltd.Donald Danforth Plant Science CenterGeomarine BiotechnologiesGlycomarMarinovaNurture Aqua Technology Pvt.New England BiolabsPicesPml Application Ltd.Global blue biotechnology market has been segmented into:By Product TypePharmaBiofuelsFoodEnzymesBiopolymersBy ApplicationVaccine developmentDrug findingGenomics By End- UserPharmaceutical companiesBiotechnology companiesResearch organizationHealthcare centreBy Regions:North America Europe Asia Pacific Middle East and Africa Latin America Rest of Latin America About Aarkstore EnterpriseAarkstore curates global market research reports from various industry verticals and serves businesses worldwide.
As market research report resellers, we at Aarkstore, partner with established publishers for both; syndicated data and customized reports.
The market research data supplied by us is up-to-date and reliable for current day industry analysis and future market forecasts equally.Avail market research reports from us and gathers critical information about customer preferences, market requirements, key drivers and challenges for your business to align your strategies with them.
Market Research Place has released a new research analysis entitled Global Autoimmune Drugs Market Research Report 2019-2025 provides deep analysis on market-size, shares supply-demand analysis, sales value and volume study of Autoimmune Drugs industry.
The report studies top players with their company profile, growth aspects, opportunities, and threats to market development.
The report covers the current evolution inside the world trade and crucial parts that affect the expansion of the market.
It offers a dynamic vision of the global scenario in terms of market size, market statistics, and the competitive situation.Market Overview:The industry overview portion of the report provides the growth analysis and historical & futuristic cost, revenue, demand and supply data.
It offers readers a holistic view of the global market.
An analysis of the industrial chain, current market fluctuations, and analysis of customers has been served in the report.DOWNLOAD FREE SAMPLE REPORT: https://www.marketresearchplace.com/report-detail/182839/request-sampleKey Points Covered In This Autoimmune Drugs Market Report:Executive Summary: It provides market size with 2018 as the base year in consideration and a yearly forecast until 2025 in terms of revenue (USD Million).Market Dynamics: Key factors that are anticipated to considerably drive or limit the market’s growth are clarified in this research study.